Global Digital Polymerase Chain Reaction (PCR) Market - Industry Trends and Forecast to 2030

TABLE OF CONTENT

1 INTRODUCTION 54
1.1 OBJECTIVES OF THE STUDY 54
1.2 MARKET DEFINITION 54
1.3 OVERVIEW OF THE GLOBAL DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET 54
1.4 LIMITATIONS 56
1.5 MARKETS COVERED 56
2 MARKET SEGMENTATION 59
2.1 MARKETS COVERED 59
2.2 GEOGRAPHICAL SCOPE 60
2.3 YEARS CONSIDERED FOR THE STUDY 61
2.4 CURRENCY AND PRICING 61
2.5 Cognate Lifesciences TRIPOD DATA VALIDATION MODEL 62
2.6 MULTIVARIATE MODELLING 65
2.7 PRODUCT TYPE LIFELINE CURVE 65
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 66
2.9 Cognate Lifesciences MARKET POSITION GRID 67
2.10 MARKET APPLICATION COVERAGE GRID 68
2.11 VENDOR SHARE ANALYSIS 69
2.12 SECONDARY SOURCES 70
2.13 ASSUMPTIONS 70
3 EXECUTIVE SUMMARY 71
4 PREMIUM INSIGHTS 73
4.1 PORTER’S FIVE FORCES 76
4.2 PESTEL ANALYSIS 77
4.3 MICRO AND MACRO ECONOMIC FACTORS 78
4.4 PENETRATION AND GROWTH PROSPECT MAPPING 78
4.5 KEY PRICING STRATEGIES 79 
5 REGULATORY COMPLIANCE 80
5.1 REGULATORY AUTHORITIES 80
5.2 REGULATORY CLASSIFICATIONS 80
5.3 REGULATORY SUBMISSIONS 80
5.4 INTERNATIONAL HARMONIZATION 81
5.5 COMPLIANCE AND QUALITY MANAGEMENT SCENARIO 82
5.6 REGULATORY CHALLENGES AND STRATEGY 82
5.6.1 REGULATORY SCENARIO IN THE U.S. 82
5.6.2 REGULATORY SCENARIO IN EUROPE 83
5.6.3 REGULATORY SCENARIO IN CHINA 83
6 MARKET OVERVIEW 84
6.1 DRIVERS 86
6.1.1 RISE IN AVAILABILITY OF DIGITAL PCR DIAGNOSTICS 86
6.1.2 INCREASING APPLICATION OF DIGITAL PCR 86
6.1.3 INCREASING DEMAND FOR PERSONALIZED MEDICINE 87
6.2 RESTRAINTS 87
6.2.1 LIMITATIONS IN ANALYZING NOVEL COMPLEX DEVICES 87
6.2.2 HIGH COST OF DIGITAL PCR DEVICES 88
6.3 OPPORTUNITIES 88
6.3.1 RISING FREQUENCY OF INFECTIOUS DISEASES 88
6.3.2 RISING PRODUCT INNOVATIONS THROUGH R&D ACTIVITIES 88
6.4 CHALLENGES 89
6.4.1 STRINGENT REGULATIONS AND LEGAL CHALLENGES FOR DIGITAL PCR 89
6.4.2 LACK OF SKILLED PROFESSIONALS PERFORMING DIGITAL PCR 89
7 GLOBAL DIGITAL POLYMERASE CHAIN REACTION (PCR)MARKET, BY PRODUCT TYPE 91
7.1 OVERVIEW 92
7.2 DIGITAL PCR INSTRUMENTS 95
7.2.1 BY MODALITY 95
7.2.1.1 STANDLONE 95
7.2.1.2 PORTABLE 95
7.2.2 BY METHOD 95
7.2.2.1 PLATE-BASED DPCR 96
7.2.2.2 CHIP BASED DPCR 96
7.2.2.3 MICROFLUIDIC CHAMBER BASED DPCR 96
7.2.2.4 OTHERS 96 
7.3 CONSUMABLES AND REAGENTS 96
7.3.1 REAGENTS 96
7.3.1.1 DNA OR PCR TEMPLATES 97
7.3.1.2 DNA POLYMERASE ENZYME 97
7.3.1.3 PRIMERS 97
7.3.1.4 DEXOYNUCLEOTIDE TRIPHOSPHATES (DNTPS) 97
7.3.1.5 PCR BUFFERS 97
7.3.1.6 PCR KIT 97
7.3.2 CONSUMABLES 98
7.3.2.1 PLATES 98
7.3.2.2 TUBES & CAPS 98
7.3.2.3 PLASTIC ACCESSORIES 98
7.3.2.4 PLATE SEALS 98
7.3.2.5 CARTRIDGES 99
7.3.2.6 OTHERS 99
7.4 SOFTWARE AND SERVICES 99
8 GLOBAL DIGITAL POLYMERASE CHAIN REACTION (PCR)MARKET, BY TECHNOLOGY 100
8.1 OVERVIEW 101
8.2 DROPLET DIGITAL PCR 104
8.2.1 CLINICAL 104
8.2.2 LIFE SCIENCE & RESEARCH 104
8.2.3 OTHERS 104
8.3 BEAMING DIGITAL PCR 105
8.3.1 CLINICAL 105
8.3.2 LIFE SCIENCE & RESEARCH 105
8.3.3 OTHERS 105
9 GLOBAL DIGITAL POLYMERASE CHAIN REACTION (PCR)MARKET, BY APPLICATION 106
9.1 OVERVIEW 107
9.2 CLINICAL 110
9.2.1 ONCOLOGY TESTING 110
9.2.2 INFECTIOUS DISEASE TESTING 110
9.2.2.1 HIV 111
9.2.2.2 HCV 111
9.2.2.3 HEPATITIS B VIRUS 111
9.2.2.4 HUMAN PAPILLOMAVIRUS 111
9.2.2.5 OTHERS 111
9.2.3 BLOOD SCREENING 111
9.2.4 TRANSPLANT DIAGNOSTICS 111
9.3 LIFE SCIENCE & RESEARCH 112
9.3.1 MICROBIOLOGY 112
9.3.2 MOLECULAR AND CELL BIOLOGY 112
9.3.3 OTHERS 112
9.4 OTHERS 112
10 GLOBAL DIGITAL POLYMERASE CHAIN (PCR) REACTION MARKET, BY END USER 113
10.1 OVERVIEW 114
10.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 117
10.3 HOSPITALS AND CLINICS 117
10.3.1 PRIVATE 117
10.3.1.1 TIER 1 117
10.3.1.2 TIER 2 118
10.3.1.3 TIER 3 118
10.3.2 PUBLIC 118
10.3.2.1 TIER 1 118
10.3.2.2 TIER 2 118
10.3.2.3 TIER 3 118
10.4 DIAGNOSTIC LABORATORIES 119
10.5 ACADEMIC AND RESEARCH ORGANIZATIONS 119
10.6 REFERENCE LABORATORIES 119
10.7 OTHERS 119